Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Impact of estrogens in males and androgens in females.

Hammes SR, Levin ER.

J Clin Invest. 2019 May 1;129(5):1818-1826. doi: 10.1172/JCI125755. Epub 2019 May 1. Review.

2.

Physiological and Pathological Androgen Actions in the Ovary.

Astapova O, Minor BMN, Hammes SR.

Endocrinology. 2019 May 1;160(5):1166-1174. doi: 10.1210/en.2019-00101.

PMID:
30912811
3.

Epigenetic Suppression of SERPINB1 Promotes Inflammation-Mediated Prostate Cancer Progression.

Lerman I, Ma X, Seger C, Maolake A, Garcia-Hernandez ML, Rangel-Moreno J, Ackerman J, Nastiuk KL, Susiarjo M, Hammes SR.

Mol Cancer Res. 2019 Apr;17(4):845-859. doi: 10.1158/1541-7786.MCR-18-0638. Epub 2019 Jan 4.

PMID:
30610107
4.

Bilateral Pheochromocytomas in a Patient with Y175C Von Hippel-Lindau Mutation.

Astapova O, Biswas A, DiMauro A, Moalem J, Hammes SR.

Case Rep Endocrinol. 2018 Jul 10;2018:8967159. doi: 10.1155/2018/8967159. eCollection 2018.

5.

A fatal case of parathyroid hormone-related peptide (PTHrP)-producing squamous cell carcinoma arising in the context of long-standing hidradenitis suppurativa.

Pitch MA, Bryan DJ, McMillan J, Chavez L, Hammes SR, Scott G, Mercurio MG, Somers KE.

JAAD Case Rep. 2018 Apr 30;4(5):426-428. doi: 10.1016/j.jdcr.2017.11.025. eCollection 2018 Jun. No abstract available.

6.

Rapid Signaling and Genomic Steroid Hormone Actions in Health and Disease.

Hammes SR.

Steroids. 2018 May;133:1. doi: 10.1016/j.steroids.2018.03.002. No abstract available.

PMID:
29563023
7.

Reflections on Endocrinology, 2013-2017.

Gore AC, Hammes SR.

Endocrinology. 2017 Dec 1;158(12):4123-4125. doi: 10.1210/en.2017-00886. No abstract available.

PMID:
29211903
8.

Neutrophil elastase in the tumor microenvironment.

Lerman I, Hammes SR.

Steroids. 2018 May;133:96-101. doi: 10.1016/j.steroids.2017.11.006. Epub 2017 Nov 16. Review.

9.

Paxillin actions in the nucleus.

Ma X, Hammes SR.

Steroids. 2018 May;133:87-92. doi: 10.1016/j.steroids.2017.10.012. Epub 2017 Oct 31. Review.

10.

Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB) and Cancer: A Novel Potential Therapeutic Target.

Taya M, Hammes SR.

Steroids. 2018 May;133:102-107. doi: 10.1016/j.steroids.2017.10.013. Epub 2017 Oct 31. Review.

11.

Androgens Regulate Ovarian Gene Expression Through Modulation of Ezh2 Expression and Activity.

Ma X, Hayes E, Biswas A, Seger C, Prizant H, Hammes SR, Sen A.

Endocrinology. 2017 Sep 1;158(9):2944-2954. doi: 10.1210/en.2017-00145.

12.

A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis.

Lu C, Lee HS, Pappas GP, Dilling DF, Burger CD, Shifren A, Veeraraghavan S, Chapman JT, Parambil J, Ruoss SJ, Young LR, Hammes SR, Kopras EJ, Roads T, Krischer JP, McCormack FX; Trial of an Aromatase Inhibitor in Lymphangioleiomyomatosis Group.

Ann Am Thorac Soc. 2017 Jun;14(6):919-928. doi: 10.1513/AnnalsATS.201610-824OC.

PMID:
28570161
13.

Infiltrating Myeloid Cells Exert Protumorigenic Actions via Neutrophil Elastase.

Lerman I, Garcia-Hernandez ML, Rangel-Moreno J, Chiriboga L, Pan C, Nastiuk KL, Krolewski JJ, Sen A, Hammes SR.

Mol Cancer Res. 2017 Sep;15(9):1138-1152. doi: 10.1158/1541-7786.MCR-17-0003. Epub 2017 May 16.

14.
15.

Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors.

Levin ER, Hammes SR.

Nat Rev Mol Cell Biol. 2016 Dec;17(12):783-797. doi: 10.1038/nrm.2016.122. Epub 2016 Oct 12. Review.

16.

Aromatase deficiency in a male patient - Case report and review of the literature.

Miedlich SU, Karamooz N, Hammes SR.

Bone. 2016 Dec;93:181-186. doi: 10.1016/j.bone.2016.09.024. Epub 2016 Sep 29. Review.

PMID:
27693882
17.

Editorial: Final Musings on the Impact of Molecular Endocrinology.

Hammes SR.

Mol Endocrinol. 2016 Oct;30(10):1027-1028. No abstract available.

18.

Minireview: Lymphangioleiomyomatosis (LAM): The "Other" Steroid-Sensitive Cancer.

Prizant H, Hammes SR.

Endocrinology. 2016 Sep;157(9):3374-83. doi: 10.1210/en.2016-1395. Epub 2016 Jul 13. Review.

19.

Estrogen maintains myometrial tumors in a lymphangioleiomyomatosis model.

Prizant H, Taya M, Lerman I, Light A, Sen A, Mitra S, Foster TH, Hammes SR.

Endocr Relat Cancer. 2016 Apr;23(4):265-80. doi: 10.1530/ERC-15-0505. Epub 2016 Feb 15.

20.

Leptin-Induced CART (Cocaine- and Amphetamine-Regulated Transcript) Is a Novel Intraovarian Mediator of Obesity-Related Infertility in Females.

Ma X, Hayes E, Prizant H, Srivastava RK, Hammes SR, Sen A.

Endocrinology. 2016 Mar;157(3):1248-57. doi: 10.1210/en.2015-1750. Epub 2016 Jan 5.

21.

Overlapping nongenomic and genomic actions of thyroid hormone and steroids.

Hammes SR, Davis PJ.

Best Pract Res Clin Endocrinol Metab. 2015 Aug;29(4):581-93. doi: 10.1016/j.beem.2015.04.001. Epub 2015 Apr 22. Review.

22.

Editorial: Selling Science in the 21st Century (Or, Trying to Teach an Old Dog New Tricks).

Hammes SR.

Mol Endocrinol. 2015 Aug;29(8):1093-4. doi: 10.1210/ME.2015-1172. No abstract available.

23.
24.

Editorial: selling your science: where preparation meets genius.

Hammes SR.

Mol Endocrinol. 2015 May;29(5):643-4. doi: 10.1210/me.2015-1099. No abstract available.

25.

Spatially defined EGF receptor activation reveals an F-actin-dependent phospho-Erk signaling complex.

Singhai A, Wakefield DL, Bryant KL, Hammes SR, Holowka D, Baird B.

Biophys J. 2014 Dec 2;107(11):2639-51. doi: 10.1016/j.bpj.2014.09.048. Epub 2014 Dec 2.

26.

Statement of principle.

Cefalu WT, Nair KS, Seaquist ER, Zierath J, Boulton AJ, LeRoith D, Harrell RM, Grunberger G, Wartofsky L, Gore AC, Wierman ME, Hammes SR, Lange CA, Santen RJ.

Horm Cancer. 2015 Feb;6(1):1. doi: 10.1007/s12672-014-0206-x. No abstract available.

PMID:
25410830
27.

Statement of principle.

Cefalu WT, Nair KS, Seaquist ER, Zierath J, Boulton AJ, LeRoith D, Harrell RM, Grunberger G, Wartofsky L, Gore AC, Wierman ME, Hammes SR, Lange CA, Santen RJ.

Endocr Rev. 2014 Dec;35(6):850. doi: 10.1210/er.2014-1089. Epub 2014 Nov 3. No abstract available.

PMID:
25365740
28.

Statement of principle.

Cefalu WT, Nair KS, Seaquist ER, Zierath J, Boulton AJ, LeRoith D, Harrell RM, Grunberger G, Wartofsky L, Gore AC, Wierman ME, Hammes SR, Lange CA, Santen RJ.

J Clin Endocrinol Metab. 2014 Dec;99(12):4376. doi: 10.1210/jc.2014-3958. No abstract available.

PMID:
25365410
29.

Editorial: Debates in graduate medical education: who will care for us when we get older?

Hammes SR.

Mol Endocrinol. 2014 Nov;28(11):1753-5. doi: 10.1210/me.2014-1311. No abstract available.

30.

Recent insights on circulating catecholamines in hypertension.

Ton QV, Hammes SR.

Curr Hypertens Rep. 2014 Dec;16(12):498. doi: 10.1007/s11906-014-0498-9. Review.

PMID:
25304108
31.

Paxillin and steroid signaling: from frog to human.

Hammes SR, Miedlich SU, Sen A.

Methods Mol Biol. 2014;1204:95-108. doi: 10.1007/978-1-4939-1346-6_9.

32.

Editorial: Sex matters in preclinical research.

Hammes SR.

Mol Endocrinol. 2014 Aug;28(8):1209-10. doi: 10.1210/me.2014-1209. Epub 2014 Jul 28. No abstract available.

33.

Lost in translation: can we afford to miss the trees for the forest?

Hammes SR, Lange CA.

Horm Cancer. 2014 Aug;5(4):203-6. doi: 10.1007/s12672-014-0187-9. No abstract available.

PMID:
24980775
34.

Simultaneous adrenal and cardiac g-protein-coupled receptor-gβγ inhibition halts heart failure progression.

Kamal FA, Mickelsen DM, Wegman KM, Travers JG, Moalem J, Hammes SR, Smrcka AV, Blaxall BC.

J Am Coll Cardiol. 2014 Jun 17;63(23):2549-2557. doi: 10.1016/j.jacc.2014.02.587. Epub 2014 Apr 2.

35.

Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression.

Sen A, Prizant H, Light A, Biswas A, Hayes E, Lee HJ, Barad D, Gleicher N, Hammes SR.

Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3008-13. doi: 10.1073/pnas.1318978111. Epub 2014 Feb 10.

36.

Uterine-specific loss of Tsc2 leads to myometrial tumors in both the uterus and lungs.

Prizant H, Sen A, Light A, Cho SN, DeMayo FJ, Lydon JP, Hammes SR.

Mol Endocrinol. 2013 Sep;27(9):1403-14. doi: 10.1210/me.2013-1059. Epub 2013 Jul 2.

37.

Two cases of malignant struma ovarii with metastasis to pelvic bone.

Steinman RA, De Castro IO, Shrayyef M, Chengazi V, Giampoli E, Van Der Sloot P, Calvi LM, Wittlin SD, Hammes SR, Hou R.

Gynecol Obstet Invest. 2013;75(2):139-44. doi: 10.1159/000345863. Epub 2013 Feb 6.

PMID:
23391779
38.

Membrane receptor cross talk in steroidogenesis: recent insights and clinical implications.

Light A, Hammes SR.

Steroids. 2013 Jun;78(6):633-8. doi: 10.1016/j.steroids.2012.12.016. Epub 2013 Feb 1. Review.

PMID:
23380369
39.

Targeted approaches toward understanding and treating pulmonary lymphangioleiomyomatosis (LAM).

Hammes SR, Krymskaya VP.

Horm Cancer. 2013 Apr;4(2):70-7. doi: 10.1007/s12672-012-0128-4. Epub 2012 Nov 27. Review.

40.

Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation.

Sen A, De Castro I, Defranco DB, Deng FM, Melamed J, Kapur P, Raj GV, Rossi R, Hammes SR.

J Clin Invest. 2012 Jul;122(7):2469-81. doi: 10.1172/JCI62044. Epub 2012 Jun 11.

41.

A local paracrine and endocrine network involving TGFβ, Cox-2, ROS, and estrogen receptor β influences reactive stromal cell regulation of prostate cancer cell motility.

Grubisha MJ, Cifuentes ME, Hammes SR, Defranco DB.

Mol Endocrinol. 2012 Jun;26(6):940-54. doi: 10.1210/me.2011-1371. Epub 2012 May 16. Erratum in: Mol Endocrinol. 2014 Feb;28(2):275.

42.

Central role for PELP1 in nonandrogenic activation of the androgen receptor in prostate cancer.

Yang L, Ravindranathan P, Ramanan M, Kapur P, Hammes SR, Hsieh JT, Raj GV.

Mol Endocrinol. 2012 Apr;26(4):550-61. doi: 10.1210/me.2011-1101. Epub 2012 Mar 8.

43.

Minireview: Recent advances in extranuclear steroid receptor actions.

Hammes SR, Levin ER.

Endocrinology. 2011 Dec;152(12):4489-95. doi: 10.1210/en.2011-1470. Epub 2011 Oct 25. Review.

44.

The physiology of integrated nuclear and extranuclear steroid signaling: introductory comments.

Hammes SR, Kelly MJ, Slingerland JM.

Steroids. 2011 Aug;76(9):821. doi: 10.1016/j.steroids.2011.05.006. Epub 2011 May 30. No abstract available.

PMID:
21645536
45.

GPCR/EGFR cross talk is conserved in gonadal and adrenal steroidogenesis but is uniquely regulated by matrix metalloproteinases 2 and 9 in the ovary.

Carbajal L, Biswas A, Niswander LM, Prizant H, Hammes SR.

Mol Endocrinol. 2011 Jun;25(6):1055-65. doi: 10.1210/me.2010-0410. Epub 2011 Mar 31.

46.

Understanding extranuclear (nongenomic) androgen signaling: what a frog oocyte can tell us about human biology.

Sen A, Prizant H, Hammes SR.

Steroids. 2011 Aug;76(9):822-8. doi: 10.1016/j.steroids.2011.02.016. Epub 2011 Feb 25. Review.

47.

GATA-like protein-1 (GLP-1) is required for normal germ cell development during embryonic oogenesis.

Strauss TJ, Castrillon DH, Hammes SR.

Reproduction. 2011 Feb;141(2):173-81. doi: 10.1530/REP-10-0376. Epub 2010 Dec 1.

PMID:
21123517
48.

Paxillin regulates androgen- and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells.

Sen A, O'Malley K, Wang Z, Raj GV, Defranco DB, Hammes SR.

J Biol Chem. 2010 Sep 10;285(37):28787-95. doi: 10.1074/jbc.M110.134064. Epub 2010 Jul 13.

49.

Just when you thought it was safe to go into the membrane: the growing complexities of extra-nuclear progesterone signaling.

Sen A, Hammes SR.

Breast Cancer Res. 2010;12(3):109. doi: 10.1186/bcr2580. Epub 2010 Jun 16.

50.

Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function.

Sen A, Hammes SR.

Mol Endocrinol. 2010 Jul;24(7):1393-403. doi: 10.1210/me.2010-0006. Epub 2010 May 25.

Supplemental Content

Loading ...
Support Center